Lyell Immunopharma, Inc. (LYEL)

26.11 +1.99 (+8.25%) USD  |  NASDAQ  |  Jan 22, 13:25
More

Lyell Immunopharma Net Non-Operating Interest Income Expense (Quarterly)

Net Non-Operating Interest Income Expense (Quarterly) Chart

View Net Non-Operating Interest Income Expense (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Non-Operating Interest Income Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade